Employment, treatment and lung function outcomes at 1-year following diagnosis of occupational hypersensitivity pneumonitis
N. Kongsupon (Birmingham (West Midlands), United Kingdom), G. Burge (Birmingham (West Midlands), United Kingdom), A. Robertson (Birmingham (West Midlands), United Kingdom), V. Moore (Birmingham (West Midlands), United Kingdom), S. Sadhra (Birmingham (West Midlands), United Kingdom), S. Burge (Birmingham (West Midlands), United Kingdom), G. Walters (Birmingham (West Midlands), United Kingdom)
Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Kongsupon (Birmingham (West Midlands), United Kingdom), G. Burge (Birmingham (West Midlands), United Kingdom), A. Robertson (Birmingham (West Midlands), United Kingdom), V. Moore (Birmingham (West Midlands), United Kingdom), S. Sadhra (Birmingham (West Midlands), United Kingdom), S. Burge (Birmingham (West Midlands), United Kingdom), G. Walters (Birmingham (West Midlands), United Kingdom). Employment, treatment and lung function outcomes at 1-year following diagnosis of occupational hypersensitivity pneumonitis. 661
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Pulmonary function trends predict mortality in patients with hypersensitivity pneumonitis Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype Year: 2018
Occupational asthma: outcome according to cessation or reduction of exposure Source: Annual Congress 2006 - Asthma at the workplace – the prognosis and the costs Year: 2006
Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia Source: Eur Respir J 2013; 41: 402-409 Year: 2013
Profiling of hypersensitivity pneumonitis diagnosed at a UK specialist service for ILD and occupational lung diseases Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways Year: 2018
Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study Source: ERJ Open Res, 5 (4) 00259-2018; 10.1183/23120541.00259-2018 Year: 2019
Early exposure or sensitization to pets and subsequent asthma: a 20-year prospective post-bronchiolitis follow-up Source: Annual Congress 2006 - Bronchiolitis in infancy, treatment and outcome Year: 2006
What is the optimal management option for occupational asthma? Source: Eur Respir Rev 2012; 21: 97-104 Year: 2012
Predicting treatment outcomes following an exacerbation of airways disease Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019
Diagnosis, course and management of hypersensitivity pneumonitis Source: Eur Respir Rev, 31 (163) 210169; 10.1183/16000617.0169-2021 Year: 2022
Mortality, morbidity and occupational exposure to airway irritating agents among men with an allergy diagnosis in adolescence Source: Annual Congress 2007 - Occupation and obstruction Year: 2007
The psychological status of COPD patients: the impact of the long-term complex treatment and pulmonary rehabilitation Source: Eur Respir J 2003; 22: Suppl. 45, 53s Year: 2003
Mortality risk prediction with ILD-GAP index in a portuguese chronic hypersensitivity pneumonitis cohort Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021
Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: A population-based study Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018
Occupational asthma: getting the diagnosis right in primary care Source: Annual Congress 2007 - Primary care: managing special cases in lung disease Year: 2007
Inflammatory biomarkers in the evaluation of two-year outcomes of omalizumab treatment in severe allergic asthma. Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018
Long-term follow-up of sensitization and lung function in bakers with flour-induced asthma after cessation of exposure Source: Eur Respir J 2001; 18: Suppl. 33, 277s Year: 2001
The predictive value of symptoms for asthma diagnosis and inhaled steroid treatment response Source: International Congress 2016 – Asthma management in primary care Year: 2016
The effectiveness of pulmonary rehabilitation including occupational therapy in patients with chronic pulmonary emphysema Source: Eur Respir J 2002; 20: Suppl. 38, 376s Year: 2002
Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-acquired pneumonia outcomes Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008